4 Firms Rep As Pfizer Buys Cancer Drug Co. In $2.3B Deal
Pharmaceutical giant Pfizer Inc. said Monday it's buying clinical-stage blood cancer treatment company Trillium in a nearly $2.3 billion deal steered by Ropes & Gray, Norton Rose Fulbright, Goodwin and Baker...To view the full article, register now.
Already a subscriber? Click here to view full article